Acute otitis media: Difference between revisions
No edit summary |
|||
| Line 39: | Line 39: | ||
===Analgesia=== | ===Analgesia=== | ||
*[[Acetaminophen]]/[[ibuprofen]] and topical benzocaine (unless perforated TM) | *[[Acetaminophen]]/[[ibuprofen]] and topical benzocaine (unless perforated TM) | ||
===[[Antibiotics]] | ===[[Antibiotics]] === | ||
''' | {{Table | ||
|type=class="wikitable " | |||
|title=2013 AAP AOM Guidelines<ref>AAP Clinical Practice Guideline The Diagnosis and Management of Acute Otitis Media http://pediatrics.aappublications.org/content/early/2013/02/20/peds.2012-3488.full.pdf </ref> | |||
|hdrs=Age!!Otorrhea!!Severe Symptoms (unilateral or bilateral)!!Bilateral w/o Otorrhea!!Unilateral w/o Otorrhea | |||
|row1=6mo-2y{{!!}}Antibiotics{{!!}}Antibiotics{{!!}}Antibiotics{{!!}}Antibiotics | |||
|row2=≥2y{{!!}}Antibiotics{{!!}}Antibiotics{{!!}}Antibiotics or observation period{{!!}}Antibiotics or observation period | |||
}} | |||
'''Also Consider In:''' | |||
*Age <6mo | *Age <6mo | ||
*Ill-appearing | *Ill-appearing | ||
| Line 48: | Line 55: | ||
*Immunocompromised | *Immunocompromised | ||
*Craniofacial abnormalities | *Craniofacial abnormalities | ||
'' | |||
*If symptoms worsen or persist | ====Wait-and-see antibiotic prescription (WASP)==== | ||
*Rather that routine perscription is an option to avoid over use if the patient does not meet any of the prescription criteria''<ref>Spiro DM. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA. 2006 Sep 13;296(10):1235-41.</ref | |||
*If symptoms worsen or persist for 48-72 then caretaker fill the prescription | |||
*Fever (relative risk [RR], 2.95; 95% confidence interval [CI], 1.75 - 4.99; P<.001) and otalgia (RR, 1.62; 95% CI, 1.26 - 2.03; P<.001) were associated with filling the prescription in the WASP group | |||
===Antibiotics=== | ===Antibiotics=== | ||
{{Otitis Media Antibiotics}} | {{Otitis Media Antibiotics}} | ||
==Complications== | ==Complications== | ||
Revision as of 13:16, 13 April 2015
Background
- Peak incidence: 6-18 months of age
- Etiology
- Viral (70% of cases)
- Bacterial
- S. pneumo (50%)
- Nontypable H. flu (30%)
- Moraxella (30%)
Diagnosis
- Acute onset (<48hr) AND
- Middle ear effusion AND
- Signs of middle ear inflammation
- Notes
- Middle Ear Effusion: bulging TM, impaired TM movement, otorrhea, or air/fluid level
- Middle Ear inflammation: erythema of TM or otalgia
Differential Diagnosis
Common
- Acute otitis media
- Chronic otitis media
- Serous otitis media
- Foreign body in external ear canal
- Otitis externa
Less common
- Accidental trauma
- Oral cavity disease (referred pain)
- Cholesteatoma
- PTA
Rare
- Mastoiditis
- Brain abscess
- Lemierre's Syndrome
- Herpes zoster oticus
Ear Diagnoses
External
- Auricular hematoma
- Auricular perichondritis
- Cholesteatoma
- Contact dermatitis
- Ear foreign body
- Herpes zoster oticus (Ramsay Hunt syndrome)
- Malignant otitis externa
- Otitis externa
- Otomycosis
- Tympanic membrane rupture
Internal
- Acute otitis media
- Chronic otitis media
- Mastoiditis
Inner/vestibular
Management
Analgesia
- Acetaminophen/ibuprofen and topical benzocaine (unless perforated TM)
Antibiotics
class="wikitable" Also Consider In:
- Age <6mo
- Ill-appearing
- Recurrent acute otitis media (w/in 2-4wk)
- Concurrent antibiotic treatment
- Other bacterial infections
- Immunocompromised
- Craniofacial abnormalities
Wait-and-see antibiotic prescription (WASP)
- Rather that routine perscription is an option to avoid over use if the patient does not meet any of the prescription criteria<ref>Spiro DM. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA. 2006 Sep 13;296(10):1235-41.</ref
- If symptoms worsen or persist for 48-72 then caretaker fill the prescription
- Fever (relative risk [RR], 2.95; 95% confidence interval [CI], 1.75 - 4.99; P<.001) and otalgia (RR, 1.62; 95% CI, 1.26 - 2.03; P<.001) were associated with filling the prescription in the WASP group
Antibiotics
Initial Treatment
High Dose Amoxicillin
- <2 months
- 30mg/kg/day PO divided q12h x 10 days
- First Dose: 15mg/kg PO x 1
- 2 months - 5 years
- 80-90mg/kg/day PO divided q12h x 10 days
- First Dose: 40-45mg/kg PO x 1
- Max: 1000mg/dose
- 6-12 years
- 80-90mg/kg/day PO divided q12h x 5-10 days
- First Dose: 40-45mg/kg/day PO x 1
- Max: 1000mg/dose
Treatment during prior Month
- If amoxicillin taken in past 30 days, Amoxicillin/Clavulanate
- 80-90mg of amoxicillin per kg/day PO divided BID x 7-10 days
- Clavulanate increases vomiting/diarrhea
- Cefdinir 14mg/kg/day BID x7-10 days
- Cefpodoxime 10mg/kg PO daily x7-10 days
- Cefuroxime 15mg/kg PO BID x7-10 days
- Cefprozil 15mg/kg PO BID x7-10 days
Otitis/Conjunctivitis
- Suggestive of non-typeable H.flu
- Amoxicillin/Clavulanate
- 80-90mg of amoxicillin per kg/day PO divided BID x 7-10 days
- Clavulanate increases vomiting/diarrhea
Treatment Failure
defined as treatment during the prior 7-10 days
- Amoxicillin/Clavulanate
- 80-90mg of amoxicillin per kg/day PO divided BID x 7-10 days
- Ceftriaxone 50mg/kg IM once as single injection x 3 days
- Use if cannot tolerate PO
Penicillin Allergy
- Azithromycin 10mg/kg/day x 1 day and 5mg/kg/day x 4 remaining days
- Clarithromycin 7.5mg/kg PO BID x 10 days
- Clindamycin 10mg/kg PO three times daily
- Clindamycin does not cover H. influenza and M. catarrhalis and treatment should favor Azithromycin use
Complications
- Mastoiditis
- Meningitis
- Brain Abscess
- Lateral Sinus Thrombosis
See Also
Sources
- Tintinalli
